Table 1. Characteristics of patient samples.

Batch #1 (8 comparisons)				Repeat Length
RE+			RIN	Short	Long	Gender	Age
2011–024	RNA16	FECD with expansion (RE+)	7.5	12	75	F	56
2011–041	RNA15	FECD with expansion (RE+)	7.8	17	85	M	78
6004	RNA19	FECD with expansion (RE+)	7.3	12	81	M	63
2011–020	RNA10	FECD with expansion (RE+)	7.7	25	56	F	75
RE-
2011–038	RNA20	FECD NO expansion (RE-)	7.6	12	19	F	81
2011–291	RNA79	FECD NO expansion (RE-)	5.9	23	26	F	79
Batch #2 (11 comparisons)
RE+
2286	RNA90	FECD with expansion (RE+)	6.2	19	71	F	59
2011–359	RNA100	FECD with expansion (RE+)	7.9	12	78	F	78
4827	RNA102	FECD with expansion (RE+)	7.9	12	48	F	80
2011–096	RNA111	FECD with expansion (RE+)	7.1	19	72	M	85
2011–353	RNA112	FECD with expansion (RE+)	7.2	15	84	F	78
2011–313	RNA 120	FECD with expansion (RE+)	6.8	16	80	M	67
2253	RNA27	FECD with expansion (RE+)	7.4	15	77	F	57
2255	RNA28	FECD with expansion (RE+)	7.3	15	79	M	75
2011–392	RNA124	FECD with expansion (RE+)	6.6	32	69	F	69
2011–369	RNA121	FECD with expansion (RE+)	6.1	15	61	M	78
2011–344	RNA114	FECD with expansion (RE+)	6.3	12	60	F	69
RE-
2011–398	RNA87	FECD NO expansion (RE-)	7.1	15	23	M	60
Batch #3 (9 comparisons)
RE+
2011–553	RNA183	FECD with expansion (RE+)	6.6	79	86	M	77
2011–573	RNA193	FECD with expansion (RE+)	6.2	15	74	F	68
2011–414	RNA141	FECD with expansion (RE+)	6.0	19	91	F	65
RE-
2011–395	RNA142	FECD NO expansion (RE-)	8.6	19	33	F	67
2011–492	RNA166	FECD NO expansion (RE-)	6.5	16	18	F	63
2011–491	RNA167	FECD NO expansion (RE-)	8.0	12	12	F	61

RIN–RNA Integrity Number